[-] Show simple item record

dc.contributor.authorPark, Michael K.eng
dc.contributor.authorSmith, Peter C.eng
dc.contributor.authorWanserski, Gerri R.eng
dc.date.issued2009-02eng
dc.description.abstractAspirin in a daily dose of 160 to 300 mg initiated within 48 hours of symptom onset results in a net decrease in morbidity and mortality caused by acute ischemic stroke (Strength of Recommendation [SOR]: A, based on a systematic review), regardless of the availability of computed tomography (CT). (SOR: A, based on a meta-analysis). Aspirin is as effective as anticoagulants in this regard and causes less harm (SOR: A, based on a systematic review), but it should not be used in patients receiving thrombolytic therapy. (SOR: B, based on one randomized controlled trial [RCT]).eng
dc.identifier.citationAmerican Family Physician, 79(3) 2009.eng
dc.identifier.urihttp://hdl.handle.net/10355/3985eng
dc.languageEnglisheng
dc.publisherFamily Physicians Inquiries Networkeng
dc.relation.ispartofClinical Inquiries, 2009 (MU)eng
dc.relation.ispartofcommunityUniversity of Missouri-Columbia. School of Medicine. Department of Family and Community Medicine. Family Physicians Inquiries Networkeng
dc.rightsOpenAccess.eng
dc.rights.licenseThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License.eng
dc.subjectatherothrombotic diseaseeng
dc.subjectInternational Stroke Trial (IST)eng
dc.subjectChinese Acute Stroke Trial (CAST)eng
dc.subjecthemorrhagic strokeeng
dc.subject.lcshCerebrovascular disease -- Treatmenteng
dc.subject.lcshAspirin -- Therapeutic useeng
dc.subject.lcshCerebrovascular disease -- Preventioneng
dc.titleAspirin in Patients with Acute Ischemic Strokeeng
dc.typeArticleeng


Files in this item

[PDF]

This item appears in the following Collection(s)

[-] Show simple item record